跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 286,888 条关于
“GO2 for Lung Cancer”
全部
286,888
临床试验
239,437
药物
4,573
机构
2,141
资讯
40,737
去年
FDA Approves FoundationOne Liquid CDx as Companion Diagnostic for Tepotinib in METex14-Skipping NSCLC
去年
FDA Grants Priority Review to Boehringer's Zongertinib for HER2-Mutant Advanced Lung Cancer
10个月前
FDA Grants Full Approval to Amgen's Imdelltra for Extensive Stage Small Cell Lung Cancer
9个月前
Zenocutuzumab Shows Superior Efficacy in Treatment-Naïve NRG1+ NSCLC Patients
去年
Multiple Cancer Clinical Trials Advance with Remote Study Models and Novel Therapeutics
3个月前
FDA Approves FoundationOne CDx as Companion Diagnostic for Tepotinib in MET Exon 14-Positive NSCLC
9年前
FDA Approves Fourth ALK Inhibitor for Lung Cancer
上个月
World Lung Cancer Day Highlights Critical Gaps in Early Screening as Lung Cancer Remains Deadliest Cancer
去年
ZL-1310 Demonstrates Promising Efficacy in Recurrent Small Cell Lung Cancer
去年
EMA Committee Recommends Repotrectinib for Advanced Lung Cancer and Solid Tumors
第 1 页,共 4074 页
上一页
下一页